Pioneering Advances of AI in Hematology – Key Takeaways from the 65th ASH Annual Meeting

Pioneering Advances of AI in Hematology – Key Takeaways from the 65th ASH Annual Meeting
3.42BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US0441861046
CUSIP
044186104
Sector
Basic Materials
Industry
Specialty Chemicals
Fiscal Year End
September
IPO date
-
Updated At
-
PE Ratio
47.56
PEG Ratio
1.23
Book Value
40.84
Dividend Share
1.665
Dividend Yield
2.23%
Earnings Share
1.56
Wall Street Target Price
80.45
EPS Estimate Current Year
3.52
EPS Estimate Next Year
4.32
EPS Estimate Current Quarter
0.9844
EPS Estimate Next Quarter
1.3748
Most Recent Quarter
-
Revenue TTM
1,842,000,000
Gross Profit TTM
615,000,000
EBITDA
364,000,000
Profit Margin
2.82%
Return On Assets TTM
2.43%
Return On Equity TTM
3.99%
Revenue Per Share TTM
40.707
Qtly Revenue Growth YOY
7.30%
Diluted Eps TTM
1.56
Qtly Earnings Growth YOY
-47.50%
Trailing PE
47.56
Forward PE
17
Price Sales TTM
1.8444
Price Book MRQ
1.8288
Enterprise Value Revenue
2
Enterprise Value EBITDA
11
204.80
0.82%40.75
0.07%4817.78
0.00%226.96
0.00%340.87
-3.38%509.20
-2.14%95.86
-1.89%22.12
-1.65%304.68
-1.49%312.97
-1.19%